About NextGen Exsome
NextGen Exsome is a company founded in 2024. It operates as a B2B. NextGen Exsome offers products and services including Exosome Separation and Purification, Exosome Protein Analysis, Exosome Particle Size Analysis, Exosome Omics Analysis, and Exosome Functional Verification. NextGen Exsome operates in a competitive market with competitors including Accent Microcell and Amster Microcell, among others.
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NextGen Exsome
NextGen Exsome offers a comprehensive portfolio of products and services, including Exosome Separation and Purification, Exosome Protein Analysis, Exosome Particle Size Analysis, Exosome Omics Analysis, and Exosome Functional Verification.
Service for isolating and purifying exosomes from samples.
Integrated technology for profiling exosome proteins.
Detects size, quantity, and purity of exosomes.
Includes genomics, lipidomics, and transcriptomics for exosomes.
Evaluates exosome functionality and pharmacological effects.
Funding Insights of NextGen Exsome
Investments & Acquisitions by NextGen Exsome
Financial Statements - NextGen Exsome
Nextgen Exsome Comparisons
Competitors of NextGen Exsome
NextGen Exsome operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Accent Microcell and Amster Microcell, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Microcrystalline cellulose and excipients are manufactured by Accent Microcell.
|
|
| domain | founded_year | HQ Location |
Produces excipients like microcrystalline cellulose for pharmaceutical and nutraceutical industries.
|
Latest news on Nextgen Exsome
Frequently Asked Questions about NextGen Exsome
NextGen Exsome was founded in 2024.
NextGen Exsome is a platform focused on the advanced manufacturing of cell and exosome engineering. It delivers services including separation, identification, omics analysis, and functional verification of exosomes. The company supports diverse sectors in medical research and therapy development through precise preparation and traceability technologies. Operating globally, it caters to research institutions and industries requiring raw materials for exosome-based applications.
NextGen Exsome's top competitors include Accent Microcell and Amster Microcell.
NextGen Exsome offers Exosome Separation and Purification, Exosome Protein Analysis, Exosome Particle Size Analysis, Exosome Omics Analysis, and Exosome Functional Verification.